Pioneer Surgical Technology today announced its acquisition of Angstrom Medica, Inc., headquartered in Woburn, MA. Angstrom is the first company to obtain FDA approval for a nanotechnology device - NanOss.
Arrowhead Research Corporation announced today that it has provided $2.4 million in additional capital to wholly-owned subsidiary, Tego Biosciences Corporation. Tego is developing and commercializing therapeutics and other products based on the antioxidant properties of modified fullerenes.
DuPont today announced an alliance with Canada-based Morph Technologies Inc., Integran Technologies Inc., and U.S.-based PowerMetal Technologies to develop and commercialize a nanocrystalline metal/polymer hybrid technology that will be used to manufacture extremely lightweight components with the strength and stiffness of metal and the design flexibility and lightweight benefits of high-performance thermoplastics.
Intradigm Corporation, a leading developer of targeted, systemic RNA interference (RNAi) therapeutics, today announced study results that demonstrated the company's TargeTran delivery system is capable of delivering vascular endothelial growth factor (VEGF) targeted small interfering RNAs (siRNAs) that suppress tumor-induced angiogenesis by silencing target gene expression in mice.
The Nano Science and Technology Institute (NSTI) is pleased to announce that abstracts are being accepted for the Merck Corporate Symposium: Targeted Delivery of siRNA, to be held during Nanotech 2008 in Boston, MA.
Nano-Proprietary, Inc. announced that its subsidiary, Applied Nanotech, Inc. (ANI), has been awarded an SBIR Phase II contract for the continued development of a "Carbon Nanotube (CNT)-Based Gas Ionizer to Replace Radioactive Sources" from the Homeland Security Advanced Research Project Agency (HSARPA).
API Nanotronics Corp., a leading supplier of electronic components and nanotechnology research and development to the defense and communications sectors, today announced the introduction of a new line of proprietary UV polarizers.
Nano Chemical Systems Holdings, Inc. announces the completion of the sale of SeaSpray Aerosol one of the Company's wholly owned subsidiaries. SeaSpray was sold in exchange for the forgiveness of $1,330,000 in debt.
Nano Chemical Systems Holdings, Inc. announces that it has reached an agreement with Dr. Mathew Zuckerman for the return of common stock in exchange for the release of any rights to certain patents that Dr. Zuckerman may have assigned or developed with the company.
Advance Nanotech, Inc. today announced that its Owlstone Nanotech subsidiary has received a purchase order for test quantities of its Lonestar product from Kidde IP Holdings Limited, the research subsidiary of UTC Fire & Security Corporation.
API Nanotronics Corp., a leading supplier of electronic components and nanotechnology research and development to the defense and communications sectors, held its annual meeting of shareholders Friday, October 19, 2007, in Toronto, Canada.
A123Systems, developer and producer of patent-pending Nanophosphate lithium ion batteries, today announced it has completed a $30 million round of funding, bringing the total capital invested in the company to $132 million.